XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.20.4

Related Party Transactions | 12 Months Ended
--- | ---
Dec. 31, 2020
Related Party Transactions [Abstract] |
Related Party Transactions | Related Party Transactions During the years ended December 31, 2020, 2019, and 2018, NMM earned approximately $16.9 million, $17.3 million, and $21.6 million, respectively, in management fees, of which $2.3 million and $2.0 million, remained outstanding, at December 31, 2020 and 2019 respectively, from LMA, which is accounted for under the equity method based on 25% equity ownership interest held by APC (see Note 6). During the years ended December 31, 2020, 2019, and 2018, APC paid approximately $2.2 million, $2.7 million, and $2.5 million, respectively, to PMIOC for provider services, which is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 6). During the years ended December 31, 2020, 2019, and 2018, APC paid approximately $6.0 million, $7.8 million, and $7.0 million, respectively, to DMG for provider services, which is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 6). During the years ended December 31, 2020, 2019, and 2018, APC paid approximately $0.5 million, $0.4 million, $0.3 million, respectively, to Advance Diagnostic Surgery Center for services as a provider. Advance Diagnostic Surgery Center shares common ownership with certain board members of APC. During the years ended December 31, 2020, 2019, and 2018, APC paid approximately $0.1 million, $0.1 million, and $0.1 million respectively, to Fresenius and their subsidiaries for services as a provider. During the year ended December 31, 2020 and 2019, APAACO paid approximately $0.7 million and $0, respectively, to Fresenius and their subsidiaries for services as a provider. One of the Company's board members is an officer of Fresenius and their subsidiaries. During the years ended December 31, 2020 and 2019, APC paid approximately $0.3 million and $0, respectively, to Fulgent Genetics, Inc. for services as a provider. Fulgent Genetics, Inc. shares common a board member with the Company starting in 2019. During the years ended December 31, 2020, 2019, and 2018, NMM paid approximately $1.0 million and $1.1 million, and $1.0 million to Medical Property Partners (“MPP”) for an office lease. MPP shares common ownership with certain board members of NMM (see Note 19). During the years ended December 31, 2020 and 2019, NMM paid approximately $1.4 million and $0.2 million, respectively, to One MSO, Inc. (“One MSO”) for an office lease. One MSO was indirectly 50% owned by Drs. Sim and Lam in 2019, but as of December 31, 2020, Drs. Sim and Lam has sold their ownership to APC for $2.4 million. During the years ended December 31, 2020, 2019, and 2018, the Company paid approximately $0.3 million, $0.5 million, and $0.4 million respectively, to Critical Quality Management Corp (“CQMC”) for an office lease. CQMC shares common ownership with certain board members of APC (see Note 19). During the years ended December 31, 2020, 2019, and 2018, SCHC paid approximately $0.4 million, $0.4 million, and $0.5 million respectively, to Numen, LLC (“Numen”) for an office lease. Numen is owned by a shareholder of APC (see Note 19). The Company has agreements with HSMSO, Aurion Corporation (“Aurion”), and AHMC for services provided to the Company. One of the Company’s board members is an officer of AHMC, HSMSO and Aurion. Aurion is also partially owned by one of the Company’s board members. The following table sets forth fees incurred and income received related to AHMC, HSMSO and Aurion Corporation (in thousands):
| Years ended December 31,
| 2020 |  | 2019
AHMC – Risk pool earnings net claims payment | $ | 28,767 |  |  | $ | 40,000 |
HSMSO – Management fees, net | (949) |  |  | (1,700) |
Aurion – Management fees | (303) |  |  | (300) |
Receipts, net | $ | 27,515 |  |  | $ | 38,000 |
The Company and AHMC has a risk sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. During the years ended December 31, 2020, 2019, and 2018, the Company has recognized risk pool revenue under this agreement of $42.6 million, $49.3 million, and $68.2 million, respectively, of which $45.3 million and $40.4 million, remain outstanding as of December 31, 2020 and 2019, respectively. During the years ended December 31, 2020, 2019, and 2018, APC paid an aggregate of approximately $33.1 million, $30.8 million, and $35.2 million, respectively, to shareholders of APC for provider services, which included approximately $9.0 million, $8.8 million, and $13.5 million, respectively, to shareholders who are also officers of APC. During the years ended December 31, 2020 and 2019, NMM paid approximately $0.1 million and $0.2 million to an Apollo board member, Matthew Mazdyasni, for consulting services. In addition, affiliates wholly-owned by the Company’s officers, including Dr. Thomas Lam, ApolloMed's Co-CEO and President, are reported in the accompanying consolidated statements of income on a consolidated basis, together with the Company’s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company’s subsidiaries as related party transactions. For equity method investments, loans receivable and line of credits from related parties, see Notes 6, 7 and 10, respectively.

X
- References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -URI http://asc.fasb.org/topic&trid=2122745 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864 + Details
Name: | us-gaap_RelatedPartyTransactionsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration